Abiopharma

🔍 HOLCOMBE GREGORY F (Director)

Company: Orange County Bancorp, Inc. /DE/ (OBT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 68,824.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By Foundation | shares_owned_after: 14,920.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By Trust 1 | shares_owned_after: 12,054.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By Trust 2 | shares_owned_after: 34,720.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By Trust 3 | shares_owned_after: 34,720.00
• Acquired 701 shares of Phantom Stock (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,847.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3

Footnotes:

• F1: Includes restricted stock units which vest 100% as of the date of grant and are settled in shares of Issuer common stock upon separation from service of the reporting person.
• F2: Includes restricted stock units which vest 100% on February 19, 2027, and are settled in shares of Issuer common stock upon separation from service of the reporting person.
• F3: Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable upon the reporting person's separation of service as a director.